Concepedia

Joao V. Alessi

JV

Statistics

Publications

37

Citations

2.6K

H-Index

26

Active since

2017

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

Memorial Sloan Kettering Cancer Center

Joao V. Alessi is an author at Dana-Farber Cancer Institute specializing in medicine, lung cancer, and immunology.

ORCID

Top concepts

Publications per year

2017–2025

37

Publications

37

Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

Biagio Ricciuti, Xinan Wang, Joao V. Alessi et al. · JAMA Oncology · 2022 · 356 citations · Full text

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status

Biagio Ricciuti, Kathryn C. Arbour, Amir Vajdi et al. · Journal of Thoracic Oncology · 2021 · 346 citations · Full text

, , +10

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Marcelo V. Negrão, Haniel A. Araújo, Giuseppe Lamberti et al. · Cancer Discovery · 2023 · 166 citations · Full text

Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)

Biagio Ricciuti, Greg Jones, Mariano Severgnini et al. · Journal for ImmunoTherapy of Cancer · 2021 · 148 citations · Full text

SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition

Joao V. Alessi, Biagio Ricciuti, Liam F. Spurr et al. · Journal of Thoracic Oncology · 2021 · 140 citations

, , +9

1–5 of 37